## Pathophysiology of CO₂ Retention with Supplemental O₂ in COPD **Key Point:** In severe COPD with chronic hypercapnia, the primary respiratory drive is hypoxemia (not hypercapnia as in healthy individuals). Supplemental oxygen removes this hypoxic stimulus, leading to hypoventilation and worsening CO₂ retention. ### Normal vs. COPD Respiratory Drive In healthy individuals, elevated PaCO₂ is the dominant stimulus for ventilation via central chemoreceptors. However, in chronic COPD with persistent hypercapnia, the respiratory center becomes desensitized to CO₂, and the peripheral chemoreceptors (responding to low PaO₂) become the primary ventilatory drive. ### Mechanism of Worsening Hypercapnia 1. **Removal of hypoxic drive:** Supplemental oxygen raises PaO₂ from 42 to 58 mmHg, reducing peripheral chemoreceptor stimulation. 2. **Loss of ventilatory stimulus:** Without the hypoxic drive, the patient hypoventilates despite persistent hypercapnia. 3. **Result:** Minute ventilation decreases → CO₂ elimination falls → PaCO₂ rises from 68 to 82 mmHg. **High-Yield:** This is why COPD patients require **controlled oxygen therapy** (target SaO₂ 88–92%) rather than high-flow oxygen. Aggressive oxygenation paradoxically worsens CO₂ retention. ### Clinical Pearl The worsening pH (7.28 → 7.25) and rising HCO₃⁻ (32 → 36) indicate acute-on-chronic respiratory acidosis with metabolic compensation. The kidneys have already compensated for chronic hypercapnia (baseline HCO₃⁻ likely ~32–35), but acute CO₂ rise outpaces renal buffering. ### Management Principle - Use **low-flow oxygen** (1–2 L/min) to target SaO₂ 88–92%. - Monitor ABG closely; if PaCO₂ rises >10 mmHg, reduce oxygen and consider non-invasive ventilation (CPAP/BiPAP) or intubation if respiratory failure progresses.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.